Questions Remain About New “Smart Drug” Modafinil Safety

0
139

A number of news outlets have been reporting on a review of modafinil, labeled the new “smart drug,” this week.  The review in question summarized the recent literature on the drug but others have claimed that the authors underestimated potential side-effects.  In the Guardian, two neuroscience researchers claim that “the jury is still out.”  ” Exercising more and avoiding sleep deprivation are both options with a much greater weight of evidence behind their cognitive benefits.”

Article →

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time